Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness
- Details
- Category: Pfizer
![Pfizer Pfizer](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
GSK launches new specialist unit to research and develop medicines for rare diseases
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
Strong operating performance for Roche in 2009
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Pfizer Reports Fourth-Quarter and Full-Year 2009 Results
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
VYVANSE® - new ADHD treatment option - now available in Canada
- Details
- Category: Shire
![Shire plc Shire plc](http://www.worldpharmanews.com/images/stories/logo/shire.gif)
Roche establishes new medical research hub in Singapore
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Lilly Reports Fourth-Quarter and Full-Year 2009 Results
- Details
- Category: Eli Lilly and Company
![Lilly Lilly](http://www.worldpharmanews.com/images/stories/logo/lilly.gif)
More Pharma News ...
- AstraZeneca Fourth Quarter and Full Year Results 2009
- New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas
- Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter
- Novartis achieves record results in 2009
- Bayer to Discontinue Phase II Clinical Trial for Long-Acting Recombinant Factor VIII
- Bayer to discontinue the LIPLONG study
- Novo Nordisk receives approval for Victoza® in Japan